Literature DB >> 26951881

Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.

Asli Nehir Aytan1, Ercan Bastu1, Irem Demiral1, Huri Bulut2, Murat Dogan1, Faruk Buyru1.   

Abstract

This prospective study aimed to determine the status of circulating levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), IL-27, IL-35, IL-37, α-1 acid glycoprotein in patients with polycystic ovary syndrome (PCOS) compared with controls and to evaluate their relation with hyperandrogenism and obesity. Forty-eight patients with PCOS (29 obese, 19 lean) and 40 healthy controls (20 obese, 20 lean) were enrolled. CRP, TNF-α, IL-27, IL-35, IL-37, α-1 acid glycoprotein, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEA-S) levels were measured. Levels of total testosterone, A4, DHEA-S were significantly higher in patients with PCOS than in controls both in the obese and lean groups, while levels of SHBG were significantly lower in all patients with PCOS than in all (p < 0.05). Free androgen index (FAI) values were significantly higher in all patients with PCOS than in all controls (all p < 0.05). Levels of CRP, TNF-α, α-1 acid glycoprotein were significantly increased in all patients with PCOS compared with all controls (all p < 0.001). FAI had a positive correlation with CRP, TNF-α, α-1 acid glycoprotein, a negative correlation with IL-27, IL-25, IL-37 (all p < 0.01). Body mass index had a negative correlation with IL-27, IL-35, IL-37, a positive correlation with α-1 acid glycoprotein, FAI (p < 0.05). The findings confirm the proinflammatory state of PCOS. Moreover, obesity along with PCOS significantly elevates the inflammatory status and hyperandrogenism.

Entities:  

Keywords:  Hyperandrogenism; inflammation; obesity; polycystic ovary syndrome

Mesh:

Year:  2016        PMID: 26951881     DOI: 10.3109/09513590.2016.1155208

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  16 in total

Review 1.  Sexual Dimorphism in Cardiovascular Disease Risk and Risk Factors Among Vegetarians: an Exploration of the Potential Mechanisms.

Authors:  Michelle Adams; Joan Sabaté
Journal:  Curr Atheroscler Rep       Date:  2019-06-22       Impact factor: 5.113

2.  Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome.

Authors:  Laura M L Carvalho; Cláudia N Ferreira; Daisy K D de Oliveira; Kathryna F Rodrigues; Rita C F Duarte; Márcia F A Teixeira; Luana B Xavier; Ana Lúcia Candido; Fernando M Reis; Ieda F O Silva; Fernanda M F Campos; Karina B Gomes
Journal:  J Assist Reprod Genet       Date:  2017-09-13       Impact factor: 3.412

3.  Chronic inflammation in polycystic ovary syndrome: A case-control study using multiple markers.

Authors:  Soumik Goswami; Subhadip Choudhuri; Basudev Bhattacharya; Rana Bhattacharjee; Ajitesh Roy; Satinath Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Int J Reprod Biomed       Date:  2021-04-22

4.  Hypothyroidism Reduces the Size of Ovarian Follicles and Promotes Hypertrophy of Periovarian Fat with Infiltration of Macrophages in Adult Rabbits.

Authors:  J Rodríguez-Castelán; M Méndez-Tepepa; Y Carrillo-Portillo; A Anaya-Hernández; J Rodríguez-Antolín; E Zambrano; F Castelán; E Cuevas-Romero
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

5.  The Lys469glu/K469E Polymorphism of the Inflammatory Gene Intercellular Adhesion Molecule-1 Lacks any Apparent Role in the Polycystic Ovary Syndrome in Kashmiri Women: A Case Control Study

Authors:  Syed Douhath Yousuf; Mohammad Ashraf Ganie; Mohammad Afzal Zargar; Shajr Ul Amin; Gulzar A Bhat; Akbar Masood; Fouzia Rashid
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

6.  Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis.

Authors:  Chan Hee Kim; Seung Joo Chon; Seon Heui Lee
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

7.  Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome.

Authors:  P Maidana; A Fritzler; Y Mocarbel; M B Perez Lana; D González; M Rosales; F González de Chazal; K Sternberg; E Lamas Majek; S Mallea-Gil; E Genovesi; M Pelayo; B Fabre; V Mesch
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

8.  ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole.

Authors:  Qin Lang; Xie Yidong; Zhang Xueguang; Wu Sixian; Xu Wenming; Zuo Tao
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

Review 9.  A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

Authors:  Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 25.261

10.  Matrix metalloproteinase-9 increases and Interleukin-10 reduces with increase in body mass index in polycystic ovary syndrome: A cross-sectional study.

Authors:  Angel Mercy Sylus; Hanumanthappa Nandeesha; Thiagaraju Chitra
Journal:  Int J Reprod Biomed       Date:  2020-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.